Biochemical properties of anti-inflammatory drugs. VII. Inhibition of proteolytic enzymes in connective tissue by chloroquine (resochin) and related antimalarial antirheumatic drugs.
D000166:Acridines / Q000494:pharmacology; D000818:Animals; D002356:Cartilage / Q000378:metabolism*; D002417:Cattle; D002738:Chloroquine / Q000378:metabolism / Q000494:pharmacology*; D002807:Chondroitin / Q000378:metabolism*; D003238:Connective Tissue / Q000378:metabolism*; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D006886:Hydroxychloroquine / Q000378:metabolism; D003012:Microbial Collagenase / Q000378:metabolism*; D009088:Mucoproteins / Q000378:metabolism*; D010206:Papain / Q000494:pharmacology; D011319:Primaquine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011817:Rabbits
D000166:Acridines; D009088:Mucoproteins; D000644:Quaternary Ammonium Compounds; D006886:Hydroxychloroquine; D002738:Chloroquine; D002807:Chondroitin; D006821:Hyaluronoglucosaminidase; D010206:Papain; D003012:Microbial Collagenase; D011796:Quinacrine; D011319:Primaquine